Zhejiang AngLiKang Pharmaceutical Co Ltd Sustainability Reports
The company researches, develops, manufactures, and sells chemical active pharmaceutical ingredients (APIs), pharmaceutical preparations, and special intermediates. Its therapeutic areas primarily focus on oral cephalosporin antibiotics, cardiovascular diseases, and renal diseases.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001TXW8V6
1 reports from 2019 to 2019